A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI
Руководство по препаратам, вызывающим дисфункцию слюнных желез, ксеростомию и субъективную сиалоррею: систематический обзор при поддержке World Workshop on Oral Medicine VI
2016-11-16
SCID: 54.1/yvpn7unm
Discuss with AI
Anatomical Therapeutic Chemical (ATC) classificationmedication-induced salivary gland dysfunctionsialogoguessubjective sialorrheaxerostomia
Figures from the paper
Abstract (AI)
BACKGROUND: Medication-induced salivary gland dysfunction (MISGD), xerostomia (sensation of oral dryness), and subjective sialorrhea cause significant morbidity and impair quality of life. However, no evidence-based lists of the medications that cause these disorders exist. OBJECTIVE: Our objective was to compile a list of medications affecting salivary gland function and inducing xerostomia or subjective sialorrhea. DATA SOURCES: Electronic databases were searched for relevant articles published until June 2013. Of 3867 screened records, 269 had an acceptable degree of relevance, quality of methodology, and strength of evidence. We found 56 chemical substances with a higher level of evidence and 50 with a moderate level of evidence of causing the above-mentioned disorders. At the first level of the Anatomical Therapeutic Chemical (ATC) classification system, 9 of 14 anatomical groups were represented, mainly the alimentary, cardiovascular, genitourinary, nervous, and respiratory systems. Management strategies include substitution or discontinuation of medications whenever possible, oral or systemic therapy with sialogogues, administration of saliva substitutes, and use of electro-stimulating devices. LIMITATIONS: While xerostomia was a commonly reported outcome, objectively measured salivary flow rate was rarely reported. Moreover, xerostomia was mostly assessed as an adverse effect rather than the primary outcome of medication use. This study may not include some medications that could cause xerostomia when administered in conjunction with others or for which xerostomia as an adverse reaction has not been reported in the literature or was not detected in our search. CONCLUSIONS: We compiled a comprehensive list of medications with documented effects on salivary gland function or symptoms that may assist practitioners in assessing patients who complain of dry mouth while taking medications. The list may also prove useful in helping practitioners anticipate adverse effects and consider alternative medications.
Key Findings
1
Medications across 9 of 14 ATC anatomical groups were implicated, chiefly alimentary, cardiovascular, genitourinary, nervous, and respiratory system drugs.
2
Objective salivary flow rates were rarely reported; xerostomia was predominantly assessed as an adverse effect rather than a primary outcome.
3
Recommended management strategies include substitution or discontinuation of causative drugs, sialogogues (oral or systemic), saliva substitutes, and electro-stimulating devices.
4
Systematic review identified 106 chemical substances with evidence of causing medication-induced salivary gland dysfunction, xerostomia, or subjective sialorrhea (56 high evidence, 50 moderate evidence).
5
The compiled medication list aims to help clinicians assess dry mouth complaints, anticipate adverse effects, and consider alternative medications.
Research Object
Medications that affect salivary gland function and induce xerostomia or subjective sialorrhea
Research Subject
Compilation and evidence-based characterization of which medications induce medication-induced salivary gland dysfunction (MISGD), xerostomia (oral dryness sensation), or subjective sialorrhea, including their ATC group distribution and management strategies
Publication Details
Publication Date
2016-11-16
Journal
Publisher
ISSN
Cited by
379
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest